Federal Supply Schedule 36F79720D0144
Award Date
6/1/20
Last Date to Order
12/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Dendreon Pharmaceuticals LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs (VA), provides the VA with a multiple award vehicle for procuring pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The prime contractor, Reliable 1 Laboratories LLC, is a self-certified small disadvantaged business that was awarded this $1,365,780.00 contract with a period of performance through July 14, 2026. The contract aims to supply the VA with a wide range of pharmaceutical and...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 of the U.S. Department of Veterans Affairs, provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Stemline Therapeutics, Inc. on August 15, 2019 and has a ceiling value of $3,950,000.00. The period of performance runs through July 14, 2025. The contract is under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, allowing the...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Ascend Therapeutics US LLC, a foreign-owned for-profit organization. The $25,000 interim agreement is under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance through September 14, 2023. As a multiple award contract, this FSS provides the VA with a pre-negotiated list of products and services that can be ordered as needed. The scope of...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides for the procurement of pharmaceutical and hematology-related products. The prime contractor, Orexo US Inc., is a for-profit manufacturer based in Morristown, New Jersey. The contract has a ceiling value of $225,000.00 and a period of performance through January 31, 2026. The scope of the contract encompasses the delivery of drugs, pharmaceuticals, and hematology-related products under...